Yigal M Pinto

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

A. Tijsen, Y. Pinto, E. Creemers, 2012, Circulation research.

Clinical utility gene card for: hypertrophic cardiomyopathy (type 1–14)

Perry M Elliott, Y. Pinto, A. Wilde, 2011, European Journal of Human Genetics.

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

Ran Elkon, Reuven Agami, Stuart A Cook, 2016, Circulation research.

52 Genetic Loci Influencing Myocardial Mass.

Christian Gieger, Thomas Meitinger, Manolis Kellis, 2016, Journal of the American College of Cardiology.

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

Dudley J Pennell, Enrico Petretto, Theodore W Kurtz, 2008, Nature Genetics.

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Tiina Heliö, Ali Yilmaz, Eloisa Arbustini, 2013, European heart journal.

Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.

Y. Pinto, E. Creemers, Esther E Creemers, 2011, Cardiovascular research.

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

Antoni Bayes-Genis, Mark Richards, Y. Pinto, 2006, European heart journal.

MiR423-5p As a Circulating Biomarker for Heart Failure

Perry D Moerland, Allard C van der Wal, A. Tijsen, 2010, Circulation research.